PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis

2020145 citationsJournal Articlehybrid Open Access

Authors

Robert Seifert · German Cancer Society

Katharina Kessel · University Hospital Münster

Katrin Schlack · University Hospital Münster

Manuel Weber · German Cancer Society

Ken Herrmann · German Cancer Society

Maximilian Spanke · German Cancer Society

Wolfgang P. Fendler ·

Abstract

PSMA-TV was a statistically significant negative prognosticator of overall survival in patients receiving Lu-PSMA therapy. PSMA-TLQ was an independent and superior prognosticator of overall survival compared with PSMA-TV.

Topics & Keywords

Prostate Cancer Treatment and Research Radiopharmaceutical Chemistry and Applications Cancer, Lipids, and Metabolism

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: European Journal of Nuclear Medicine and Molecular Imaging

Volume 48, Issue 4, pp. 1200-1210

DOI: 10.1007/s00259-020-05040-1

Field-Weighted Citation Impact: 9.63